BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 16156145)

  • 1. Pars plana vitrectomy for ocular complications of Behçet's disease.
    Sullu Y; Alotaiby H; Beden U; Erkan D
    Ophthalmic Surg Lasers Imaging; 2005; 36(4):292-7. PubMed ID: 16156145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 23-gauge vitrectomy in 100 eyes: short-term visual outcomes and complications.
    Lott MN; Manning MH; Singh J; Zhang H; Singh H; Marcus DM
    Retina; 2008 Oct; 28(9):1193-200. PubMed ID: 18626419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of 77 consecutive cases of 23-gauge transconjunctival vitrectomy surgery for posterior segment disease.
    Fine HF; Iranmanesh R; Iturralde D; Spaide RF
    Ophthalmology; 2007 Jun; 114(6):1197-200. PubMed ID: 17544779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 27-gauge instrument system for transconjunctival sutureless microincision vitrectomy surgery.
    Oshima Y; Wakabayashi T; Sato T; Ohji M; Tano Y
    Ophthalmology; 2010 Jan; 117(1):93-102.e2. PubMed ID: 19880185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of 27 Gauge Microincision Vitrectomy Surgery for Posterior Segment Disease.
    Khan MA; Shahlaee A; Toussaint B; Hsu J; Sivalingam A; Dugel PU; Lakhanpal RR; Riemann CD; Berrocal MH; Regillo CD; Ho AC
    Am J Ophthalmol; 2016 Jan; 161():36-43.e1-2. PubMed ID: 26429584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phacoemulsification cataract extraction and intraocular lens implantation in patients with Behçet's disease.
    Berker N; Soykan E; Elgin U; Ozkan SS
    Ophthalmic Surg Lasers Imaging; 2004; 35(3):215-8. PubMed ID: 15185789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vitrectomy with peeling retinal limiting membrane (ILM) in eyes with diabetic macular edema].
    Oficjalska-Młyńczak J; Jamrozy-Witkowska A; Muzyka-Woźniak M; Turno-Krecicka A; Gołebiowska B
    Klin Oczna; 2006; 108(7-9):273-7. PubMed ID: 17290822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term outcomes of 23-gauge pars plana vitrectomy.
    Gupta OP; Ho AC; Kaiser PK; Regillo CD; Chen S; Dyer DS; Dugel PU; Gupta S; Pollack JS
    Am J Ophthalmol; 2008 Aug; 146(2):193-197. PubMed ID: 18547538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitrectomy for persistent panuveitis in Behçet's disease.
    Ahn JK; Chung H; Yu HG
    Ocul Immunol Inflamm; 2005 Dec; 13(6):447-53. PubMed ID: 16321889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ["Floaterectomy"--pars-plana-vitrectomy for vitreous opacities].
    Weber-Varszegi V; Senn P; Becht CN; Schmid MK
    Klin Monbl Augenheilkd; 2008 May; 225(5):366-9. PubMed ID: 18454374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitreomacular traction syndrome: impact of anatomical configuration on anatomical and visual outcomes.
    Sonmez K; Capone A; Trese MT; Williams GA
    Retina; 2008 Oct; 28(9):1207-14. PubMed ID: 19430388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 25-Gauge transconjunctival sutureless pars plana vitrectomy.
    Yanyali A; Celik E; Horozoglu F; Oner S; Nohutcu AF
    Eur J Ophthalmol; 2006; 16(1):141-7. PubMed ID: 16496259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pars plana vitrectomy in ocular Behçet's disease.
    Soylu M; Demircan N; Pelit A
    Int Ophthalmol; 2001; 24(4):219-23. PubMed ID: 12678399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pars plana vitrectomy for vitreoretinal complications of ocular toxoplasmosis.
    Adan A; Giralt J; Alvarez G; Alforja S; Burés-Jesltrup A; Casaroli-Marano RP; Corcostegui B
    Eur J Ophthalmol; 2009; 19(6):1039-43. PubMed ID: 19882570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of vitrectomy for diffuse nontractional diabetic macular edema.
    Kumagai K; Furukawa M; Ogino N; Larson E; Iwaki M; Tachi N
    Retina; 2009 Apr; 29(4):464-72. PubMed ID: 19289987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of 140 consecutive cases of 25-gauge transconjunctival surgery for posterior segment disease.
    Lakhanpal RR; Humayun MS; de Juan E; Lim JI; Chong LP; Chang TS; Javaheri M; Fujii GY; Barnes AC; Alexandrou TJ
    Ophthalmology; 2005 May; 112(5):817-24. PubMed ID: 15878061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Decrease of the postoperative inflammatory reaction during pars plana vitrectomy (PPV) after administration of triamcinolone acetonide].
    Mańkowska A; Rejdak R; Oleszczuk A; Kiczyńska M; Łekawa A; Choragiewicz T; Zagórski Z
    Klin Oczna; 2008; 110(4-6):151-4. PubMed ID: 18655452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of combined sutureless vitrectomy with triamcinolone stain to manage vitreous loss resulting from posterior capsule rupture during phacoemulsification.
    Chang CJ; Chiang SY; Chen CL; Wang TY
    J Cataract Refract Surg; 2006 Dec; 32(12):2054-9. PubMed ID: 17137983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vitrectomy surgery for the treatment of the vitreo-retinal complications of the pars planitis].
    Molina-Prat N; Adán AM; Mesquida M; Pelegrini L; Rey A; Alvarez G
    Arch Soc Esp Oftalmol; 2010 Oct; 85(10):333-6. PubMed ID: 21168058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Idiopathic vitreomacular traction syndrome. Vitrectomy results].
    Rouhette H; Gastaud P
    J Fr Ophtalmol; 2001 May; 24(5):496-504. PubMed ID: 11397986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.